NCT03807011

Brief Summary

This study was performed to assess the effects of continuous remifentanil infusion and single bolus administration of fentanyl on the incidence of emergence agitation in pediatrics undergoing strabismus surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 7, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 5, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 14, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 16, 2019

Completed
Last Updated

January 23, 2019

Status Verified

January 1, 2019

Enrollment Period

1.2 years

First QC Date

January 14, 2019

Last Update Submit

January 20, 2019

Conditions

Keywords

Emergence Agitationfentanylremifentanilchildren

Outcome Measures

Primary Outcomes (4)

  • incidence of postoperative agitation

    0=none; 1=occur

    5 minutes in the recovery room

  • incidence of postoperative agitation

    0=none; 1=occur

    30 minutes in the recovery room

  • severity of postoperative agitation

    Four-point agitation scale (0=calm; 1=not calm but could easily become calmed; 3=not easily calmed, moderately agitated and restless; 4=combative, excited, or disoriented)

    5 minutes in the recovery room

  • severity of postoperative agitation

    Four-point agitation scale (0=calm; 1=not calm but could easily become calmed; 3=not easily calmed, moderately agitated and restless; 4=combative, excited, or disoriented)

    30 minutes in the recovery room

Study Arms (2)

fentanyl

ACTIVE COMPARATOR

A bolus dose of fentanyl 2 μg/kg was administered intravenously at anesthetic induction

Drug: fentanyl group

remifentanil

ACTIVE COMPARATOR

Remifentanil was continuously infused at a rate of 0.2 μg/kg/min from anesthetic induction to the end of surgery

Drug: remifentanil group

Interventions

fentanyl 2 μg/kg

fentanyl

remifentanil 0.2 μg/kg/min

remifentanil

Eligibility Criteria

Age2 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • patients undergoing elective subumbilical surgery,
  • physical status was American Society of Anesthesiologists (ASA) class 1 or 2

You may not qualify if:

  • history of airway problem,
  • upper respiratory tract infection within 2 weeks,
  • developmental delay,
  • neurological or psychological disease,
  • history of allergy to the drugs in our protocol were excluded in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Eun kyung Choi

Daegu, Korea (the Republic Of), 41944, South Korea

Location

Yeungnam University Hospital

Daegu, Nam-gu, Daegu, 42415, South Korea

Location

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 14, 2019

First Posted

January 16, 2019

Study Start

July 7, 2017

Primary Completion

October 5, 2018

Study Completion

October 5, 2018

Last Updated

January 23, 2019

Record last verified: 2019-01

Locations